NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
5.71
-0.17 (-2.89%)
Mar 6, 2026, 4:00 PM EST - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $60.83 million as of March 6, 2026. Its market cap has increased by 263.83% in one year.
Market Cap
60.83M
Enterprise Value
56.95M
1-Year Change
263.83%
Ranking
Category
Stock Price
$5.71
Market Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $60.83M, an increase of 231.09%. That is a compound annual growth rate of 59.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 60.83M | 25.77% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TScan Therapeutics | 63.56M |
| ImageneBio | 62.84M |
| Mereo BioPharma Group | 62.71M |
| eXoZymes | 61.43M |
| Instil Bio | 60.16M |
| Spruce Biosciences | 59.80M |
| Grace Therapeutics | 59.73M |
| ImmuCell | 59.70M |